Longboard Pharmaceuticals Inc. is spinning out from Arena Pharmaceuticals Inc., courtesy of a $56 million financing to help develop CNS-targeted therapies. On the table to be developed are compounds ...
On Monday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) saw its price target increased to $36.00 from $30.00, while its stock rating remained a Buy, as announced by a B.Riley analyst. This adjustment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results